medline.ch Neurologie Multiple Sklerose

	Enhancing the endocannabinoid system to treat residual disease in relapse-free multiple sclerosis. Front Neurol Annovazzi P, Clerico M, Cocco E, Conte A, Marfia GA, Salvetti M, Tomassini V, Totaro R, Centonze D. PMID: 41859417 [PubMed]
	Targeting lipocalin-2 for multiple sclerosis: a dual role in diagnosis and therapy. Front Immunol Afridi R, Lee WH, Song M, Suk K. PMID: 41859100 [PubMed - indexed for MEDLINE]
	A potential of serum anti-C1P IgG antibodies as biomarkers in differential diagnosis of relapsing-remitting multiple sclerosis. Sci Rep Chojdak-Lukasiewicz J, Jakubiak-Augustyn A, Szulc ZM, Gubernator J, Blazej P, Pokryszko-Dragan A, Budrewicz S, Podbielska M. PMID: 41857147 [PubMed - in process]
	Resting-State EEG Microstates as Dynamic Biomarkers of Network Dysfunction and Cognitive Impairment in Patients With Multiple Sclerosis. Neurology Leodori G, Maccarrone D, Mancuso M, De Bartolo MI, Collura A, Pellegrini S, Malimpensa L, Satriano F, Fratino M, Belvisi D, Ferrazzano G, Centonze D, Conte A. PMID: 41855451 [PubMed - indexed for MEDLINE]
	The cerebellar cognitive affective syndrome scale in early multiple sclerosis. J Neurol Miscioscia A, Silvestri E, Puthenparampil M, Scialpi G, Berardi A, Colpo M, Vallini G, Anglani M, Rinaldi F, Perini P, Mainero C, Bertoldo A, Gallo P. PMID: 41854895 [PubMed - indexed for MEDLINE]
	International Expert Opinion on Optimal Switching to Cladribine Tablets from Other High-Efficacy Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: Opportunities and Challenges. Neurol Ther Chan A, Alroughani R, Calabrese M, Havrdová EK, Obeidat AZ, Schmierer K, Andersson M, Bek L, Savarin C, Korich J, Bonsignore L, de Seze J. PMID: 41854800 [PubMed - as supplied by publisher]
	Neural correlates of pure apathy in multiple sclerosis: An exploratory neuroimaging study. J Neuropsychol Torchia V, Gramigna V, Gaita M, Spitaleri D, Costanzo A, Palermo L, d'Onofrio F, Raimo S. PMID: 41854515 [PubMed - as supplied by publisher]
	Translation, cross-cultural adaptation, and psychometric properties of the Arabic version of the Rivermead Mobility Index (RMI) scale for patients with multiple sclerosis. Disabil Rehabil Albishi AM, Almhawas SS, Alshammari ZS. PMID: 41854053 [PubMed - as supplied by publisher]
	Brain Age Estimation on T2-FLAIR Scans for Application to Multiple Sclerosis. Hum Brain Mapp Colman J, Pontillo G, Goodkin O, Foster MA, Mahmoudi N, Wattjes MP, Brunetti A, Gonzalez-Escamilla G, Groppa S, Høgestøl EA, Westlye LT, Messina S, Palace J, Cortese R, De Stefano N, Rovira À, Sastre-Garriga J, Ropele S, Enzinger C, Rocca MA, Filippi M, Bellenberg B, Lukas C, Calabrese M, Castellaro M, Uher T, Vaneckova M, Toosy A, Ciccarelli O, Yousry T, Prados F, Barkhof F, Cole JH, MAGNIMS Study Group. PMID: 41853885 [PubMed - indexed for MEDLINE]
	An updated review of the economic burden of multiple sclerosis: direct and indirect costs. Front Immunol Lanza-Leon P, Cantarero-Prieto D, Coca de Pablo D, Colon Lopez De Dicastillo A, Tarquini Rodriguez L, Riancho J. PMID: 41853290 [PubMed - indexed for MEDLINE]
	Deep gray matter atrophy mediates the associations between glymphatic dysfunction and clinical disability in relapsing-remitting multiple sclerosis: a neuroimaging subgroup study. Front Immunol Zhang H, Gong R, Fu H, Jiao J, Li M, Song Z, Zhang Z, Jiang Y, Han Y, Shi F, Cao J, Cui L. PMID: 41853268 [PubMed - indexed for MEDLINE]
	Comparative profiling of neurological and biomarker status in type 1 diabetes and multiple sclerosis: A cross-sectional observational study. Brain Behav Immun Health Cano-Cano F, Cruz-Gómez ÁJ, Forero L, Lara-Barea A, Lozano-Soto E, Espinosa-Rosso R, Rashid-López R, Alcalde-Vílchez E, Álvarez-Ramos P, Aguilar-Diosdado M, Arroba AI, González-Rosa JJ. PMID: 41852950 [PubMed]
	Patient Preferences Towards Plain Language Resources During their Multiple Sclerosis Journey: A Qualitative Interview Study. Patient Pal A, Elger BS, Allemann SS, Wangmo T. PMID: 41851417 [PubMed - as supplied by publisher]
	Deciphering the missing links between Friedreich ataxia and multiple sclerosis for targeted drug development. Drug Discov Today Kwa FAA, Anjomani-Virmouni S, Ramchunder Z, Kendal E, Xiao J. PMID: 41850598 [PubMed - as supplied by publisher]
	Neutropenia after ocrelizumab treatment in patients with multiple sclerosis: A single-centre case series and systematic review of literature. Mult Scler Relat Disord Silva JA, Delgado S, Santos M, Leitão L. PMID: 41850122 [PubMed - as supplied by publisher]
	Effect of Dalfampridine on cognition, gait and fatigue in patients with multiple sclerosis: a randomized placebo-controlled study. Mult Scler Relat Disord Abdeldayem MME, Abdelnasser A, Khalil SH, Hamid E, Abousteit AM, Abushady EM, Shalash A. PMID: 41850121 [PubMed - as supplied by publisher]
	A target trial emulation of the CONFIRM study with an extension to subgroups: an example for relapsing-remitting multiple sclerosis. Eur J Epidemiol Verweij S, Bijlsma MJ, Rengerink KO, Hillert J, Forsberg L, Mouresan EF, Glaser A, Fox RJ, Hak E, Mol P. PMID: 41849089 [PubMed - as supplied by publisher]
	Characterisation of Ocular Manifestations in Patients with Multiple Sclerosis in Colombia: A Multicentric Study. Neuroophthalmology Manrique-Samer A, Cifuentes-González C, Álvarez-Martínez JV, Rojas-Carabali W, Cortes-Albornoz MC, Vélez Van-Meerbeke A, Ortiz-Salas PA, Casallas-Vanegas A, Guío-Sánchez CM, Cardona-López J, Mejía-Salgado G, de-la-Torre A. PMID: 41847272 [PubMed]
	Targeting Epstein-Barr virus (EBV) for treatment of multiple sclerosis. Mult Scler Relat Disord Soldan SS, Messick TE, Lieberman PM. PMID: 41846093 [PubMed - as supplied by publisher]
	Treatment-free remission in MS: long-term disease control with cladribine tablets. J Neurol Wiendl H, Gold R, Pul R, Ernst M, Kowarik MC, Klehmet J, Siglienti I, Hübschen M, Wagner T, Knaup J, Kleinschnitz C. PMID: 41844910 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 43577

Seite 1 von 2179

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung